These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 18508633)
41. Pattern of trisomy 1q in hematological malignancies: a single institution experience. Djordjević V; Dencić-Fekete M; Jovanović J; Drakulić D; Stevanović M; Janković G; Gotić M Cancer Genet Cytogenet; 2008 Oct; 186(1):12-8. PubMed ID: 18786437 [TBL] [Abstract][Full Text] [Related]
45. Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome. Iurlo A; Mecucci C; Van Orshoven A; Michaux JL; Boogaerts M; Noens L; Bosly A; Louwagie A; Van Den Berghe H Cancer Genet Cytogenet; 1989 Dec; 43(2):227-41. PubMed ID: 2598167 [TBL] [Abstract][Full Text] [Related]
49. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category. Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278 [TBL] [Abstract][Full Text] [Related]
50. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612). Slovak ML; Kopecky KJ; Wolman SR; Henslee-Downey JP; Appelbaum FR; Forman SJ; Blume KG Leuk Res; 1995 Jun; 19(6):381-8. PubMed ID: 7596150 [TBL] [Abstract][Full Text] [Related]
51. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia. Xu W; Li JY; Liu Q; Zhu Y; Pan JL; Qiu HR; Xue YQ Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e86-95. PubMed ID: 20089000 [TBL] [Abstract][Full Text] [Related]
52. Chromosome abnormalities in human cancer and leukemia. Sandberg AA Mutat Res; 1991 Apr; 247(2):231-40. PubMed ID: 2011141 [TBL] [Abstract][Full Text] [Related]
53. Association of loss of heterozygosity with cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome. Pinheiro RF; Serio FM; Silva MR; Briones MR; Chauffaille ML Braz J Med Biol Res; 2008 Jul; 41(7):610-4. PubMed ID: 18719743 [TBL] [Abstract][Full Text] [Related]
54. [Chromosome abnormalities in early cancers]. Maeda S; Horio M; Kitazawa S; Sugiyama T Gan No Rinsho; 1988 Aug; 34(10):1264-72. PubMed ID: 3172486 [TBL] [Abstract][Full Text] [Related]
55. Applications of Fluorescence In Situ Hybridization Technology in Malignancies. Tansatit M Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016 [TBL] [Abstract][Full Text] [Related]
56. Two cases assessed for myeloid disorders had an unexpected twist. Reddy KS Cancer Genet Cytogenet; 2008 Mar; 181(2):138-40. PubMed ID: 18295667 [No Abstract] [Full Text] [Related]
60. Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy. Ok CY; Leventaki V; Wang SA; Dinardo C; Medeiros LJ; Konoplev S Am J Clin Pathol; 2016 Feb; 145(2):271-6. PubMed ID: 26800764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]